Interim analysis of a phase 2a double-blind study of telaprevir in combination with pegIFN-a2a and ribavirin in HIV/HCV co-infected patients - Sulkowski, M; Dieterich, D; Sherman, K (18th CROI, 2011)
abstract 146LB